"Early Cancer Signs Detectable Years Before Symptoms, Reveals Pioneering Research"

The newly opened Early Cancer Institute at Cambridge University is focusing on detecting changes in cells years before they become tumors, aiming to revolutionize cancer treatment. The institute has received £11m in funding and is developing innovative tests, such as the cytosponge, to detect precancerous conditions early on. By repurposing blood samples, researchers have identified genetic changes that differentiate those who later develop blood cancer from those who do not, providing a long window of opportunity for intervention. The institute's strategy includes pinpointing those at risk of cancer, reducing cancer risks, and ensuring widely administered treatments.